Editor's Note From December 14 to December 23, 2020, monitoring by the Center for Disease Control and Prevention’s (CDC’s) Vaccine Adverse Event Reporting System found 4,393 (0.2%) adverse events after administration of 1,893,360 first doses of the Pfizer/BioNTech COVID-19 vaccine. Of these adverse events, 21 were determined to be cases…
Editor’s Note As of January 5, the Centers for Disease Control and Prevention (CDC) reports that the number of distributed COVID-19 vaccines from Pfizer/BioNTech and Moderna is 17,020,575 doses, with 4,836,469 already administered.
Editor’s Note On December 20, 2020, the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) updated its interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be offered to persons aged 75 years or more and non-healthcare frontline essential workers. In Phase 1c, the vaccine should be…
Editor's Note The Centers for Disease Control and Prevention reported on January 2, 2021, that a total of 13,071,925 COVID-19 vaccine doses had been distributed, and more than 4.2 million had been administered, according to the January 2 Reuters. The report also noted that 2,217,025 of the doses, which comprise…
Editor's Note Association for Professionals in Infection Control and Epidemiology (APIC) President Connie Steed, MSN, RN, CIC, FAPIC, on December 16, issued a statement urging healthcare workers and the public to get vaccinated with the COVI-19 vaccines when they are available. APIC supports the Centers for Disease Control and Prevention’s…
Editor's Note The first batch of the Pfizer/BioNTech's newly authorized COVID-19 vaccine for emergency use reached 141 of 145 targeted locations on the first day of its national rollout, a Department of Health and Human Services spokeswoman told Reuters. Four island territories—American Samoa, Guam, North Mariana Islands, and the US…
Editor's Note The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine. The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December…
Editor's Note Gen Gustave Perna, who oversees logistics for Operation Warp Speed, announced December 8 that the government is prepared to distribute 2.9 million doses of Pfizer/BioNTech’s COVID-19 vaccine by the end of this week or immediately after the vaccine receives emergency use authorization (EUA) from the Food and Drug…
Editor's Note This study led by researchers at the Centers for Disease Control and Prevention (CDC) finds that implementing and monitoring adherence to recommended COVID-19 mitigation strategies can reduce the risk for transmission in child care settings. In collaboration with the Department of Health and Human Services’ Administration for Children…
Editor's Note The Centers for Disease Control and Prevention (CDC) on December 2 changed its recommended quarantine period for people who have come in contact with COVID-19 positive individuals. Instead of the standard 14 days, the CDC now allows individuals who have come in contact with someone infected with the…